|
0
|
|
Oral metronidazole versus clindamycin to treat bacterial vaginosis in pregnancies at risk for preterm labor.
(linkinghub.elsevier.com)
|
Nachum Z
…
Yefet E
Clinical Microbiology and Infection
2026-06-29
|
#bacterial vaginosis
#preterm labor
#pregnancy
#amr
#clinical trial
|
|
0
|
|
Efficacy and safety of a radiographic severity-stratified all-oral short treatment regimen for multidrug/rifampicin-resistant tuberculosis in China: An open-label, multi-center,randomized controlled, non-inferiority trial.
(linkinghub.elsevier.com)
|
Sun WW
…
Fan L
Clinical Microbiology and Infection
2026-06-29
|
#tb
#mdr-tb
#clinical trial
#chemotherapy
#amr
|
|
0
|
|
Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial.
(linkinghub.elsevier.com)
|
Rouphael N
…
Frenck RW Jr
Lancet Infectious Diseases
2026-06-30
|
#vaccination
#shigellosis
#live-attenuated
#clinical trial
#immunogenicity
|
|
0
|
|
High-dose furmonertinib as first-line treatment for untreated EGFR-mutated advanced NSCLC with central nervous system metastases: A phase 2 trial.
(linkinghub.elsevier.com)
|
Yan H
…
Zhang Y
Cell Reports Medicine
2026-06-30
|
#nsclc
#brain-metastases
#egfr-mutation
#targeted therapy
#clinical trial
|
|
0
|
|
Multi-antigen-targeting T cells in pediatric central nervous system tumors: a phase 1 trial.
(nature.com)
|
Gomez S
…
Hwang EI
Nature Medicine
2026-06-30
|
#immunotherapy
#glioma
#t cell
#pediatric
#clinical trial
|
|
0
|
|
Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
Pan HX
…
Xia NS
Lancet Infectious Diseases
2026-06-30
|
#vaccination
#immunogenicity
#hpv
#clinical trial
#cervical cancer
|
|
0
|
|
Safety and Immunogenicity of the Live-Attenuated Quadrivalent Dengue Vaccine V181 Compared With Butantan-DV Among Healthy Adults in Brazil: A Randomized, Double-Blind, Phase 2 Trial.
(academic.oup.com)
|
Alexanderian D
…
Anez G
Clinical Infectious Diseases
2026-07-01
|
#vaccination
#dengue
#immunogenicity
#safety
#clinical trial
|
|
0
|
|
A review of the randomized clinical trial results from the Staphylococcus aureus network adaptive platform (SNAP) meticillin-susceptible (MSSA) and penicillin-susceptible (PSSA) domains and CloCeBa.
(academic.oup.com)
|
Goodman AL
…
Davis JS
Journal of Antimicrobial Chemotherapy
2026-07-02
|
#bacteremia
#clinical trial
#infection
#amr
#nephrotoxicity
|
|
0
|
|
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.
(nejm.org)
|
Choueiri TK
…
Powles TB
New England Journal of Medicine
2026-07-02
|
#immunotherapy
#carcinoma
#clinical trial
#adjuvant
#hif-inhibitor
|
|
0
|
|
Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.
(nejm.org)
|
Torkildsen O
…
Myhr KM
New England Journal of Medicine
2026-07-02
|
#multiple sclerosis
#immunotherapy
#antibody
#clinical trial
#autoimmunity
|
|
0
|
|
[(177)Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
(linkinghub.elsevier.com)
|
Walter T
…
Capdevila J
The Lancet
2026-07-02
|
#neuroendocrine
#radionuclide
#clinical trial
#cancer
#targeted therapy
|
|
0
|
|
Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial.
(nature.com)
|
Theodore DA
…
Sobieszczyk ME
Nature Medicine
2026-07-07
|
#antibody
#hiv
#clinical trial
#immunotherapy
#vaccination
|
|
0
|
|
Subgroup Analysis of Pooled Phase 3 Efficacy Data from Two Randomized Trials of Gepotidacin Versus Nitrofurantoin in Uncomplicated Urinary Tract Infections (EAGLE-2 and EAGLE-3) including Participants with Uropathogens Not-Susceptible to Nitrofurantoin.
(academic.oup.com)
|
Sheets A
…
Janmohamed S
Clinical Infectious Diseases
2026-07-08
|
#uti
#amr
#antibiotic
#clinical trial
|
|
0
|
|
Efficacy and safety of rivaroxaban, colchicine, and famotidine-loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial.
(linkinghub.elsevier.com)
|
Lancet Infectious Diseases
2026-07-08
|
#long covid
#fatigue
#clinical trial
#therapeutics
|
|
0
|
|
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRAS(G12D)-mutant pancreatic cancer: a phase 1b/2 trial.
(nature.com)
|
Cui J
…
Wang L
Nature Medicine
2026-07-09
|
#oncology
#pancreatic cancer
#clinical trial
#targeted therapy
#chemotherapy
|
|
0
|
|
Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
Davids MS
…
Wierda WG
The Lancet
2026-07-09
|
#leukemia
#lymphoma
#clinical trial
#immunotherapy
#pharmacotherapy
|
|
0
|
|
Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTE): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.
(linkinghub.elsevier.com)
|
Dezza FC
…
Rodriguez-Bano J
The Lancet
2026-07-09
|
#bacteraemia
#amr
#clinical trial
#antibiotic
#enterobacterales
|
|
0
|
|
Ensartinib in Resected ALK-Positive Non-Small-Cell Lung Cancer.
(nejm.org)
|
Yue D
…
Wang C
New England Journal of Medicine
2026-07-09
|
#lung cancer
#targeted therapy
#alk-inhibitor
#adjuvant
#clinical trial
|
|
0
|
|
Setmelanotide for the Treatment of Acquired Hypothalamic Obesity.
(nejm.org)
|
Miller JL
…
Roth CL
New England Journal of Medicine
2026-07-09
|
#obesity
#hypothalamic
#clinical trial
#pharmacotherapy
#melanocortin
|
|
0
|
|
Inhaled treprostinil and the vascular turn in pulmonary fibrosis.
(linkinghub.elsevier.com)
|
Yanagihara T
…
Kolb M
Cell Med
2026-07-10
|
#pulmonary fibrosis
#clinical trial
#vasodilation
#therapeutics
|